Lv1
30 积分 2023-08-20 加入
T cell-engaging therapies — BiTEs and beyond
2小时前
已完结
Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients
14天前
已完结
Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations
15天前
已完结
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLC
15天前
已完结
Screening for breast cancer brain metastases
1个月前
已完结
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
1个月前
已完结
Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R
1个月前
已完结
Pembrolizumab Retreatment: Lessons from a Selected Group of Patients with Urothelial Carcinoma
1个月前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
1个月前
已完结
Towards biomarker-driven therapies for urothelial carcinoma
1个月前
已完结
皖公网安备34019202002308
